Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations-Reference-Cited by-同舟云学术

Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations

Published:2018-05 Issue:3 Volume:17 Page:333-340
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Roberts James M.,Dai Darlene L.Y.,Hollander Zsuzsanna,Ng Raymond T.,Tebbutt Scott J.,Wilcox Pearce G.,Sin Don D.,Quon Bradley S.

Funder

British Columbia Lung Association

Providence Health Care Research Institute

Cystic Fibrosis Canada

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference36 articles.

1. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis;Goss;Thorax,2007

2. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials;Bilton;J Cyst Fibros,2011

3. 2015 annual report. Bethesda, Maryland;Cystic Fibrosis Foundation Patient Registry,2016

4. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis;Britto;Chest,2002

5. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis;Sanders;Pediatr Pulmonol,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale;BMC Pulmonary Medicine;2024-07-24

2. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale;2023-09-13

3. Recent advances in proteomic-based diagnostics of cystic fibrosis;Expert Review of Proteomics;2023-09-02

4. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine;Frontiers in Medical Technology;2023-01-04

5. Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D;Journal of Cystic Fibrosis;2022-11